Liver Cirrhosis Clinical Trial
Official title:
Validation of the Bispectral Index Monitor During Living Donor Liver Transplantation
Bispectral index (BIS) monitoring during living donor liver transplantation (LDLT) may be
influenced with several factors rather than the depth of anesthesia such as bradycardia,
hypotension, hypothermia, and mixed venous oxygen saturation (SvO2). The investigators
tested the validity and the independent factors which may alter of BIS readings during LDLT.
Up to the investigators best knowledge, the independent predictors for BIS monitoring were
not identified yet during the three phases of liver transplantation.
Forty two American Society of Anesthesiologists physical class III-IV patients aged 20-50
years with severe liver dysfunction (Child-Pugh Class C) due to liver cirrhosis undergoing
living donor liver transplantation in the Mansoura University Liver Transplantation Program
from 2007 to 2010 were included in this prospective, observational study after obtaining
approval of the local ethical committee and an informed written consent from all
participants. The etiology of liver cirrhosis was hepatitis C, Budd Chiari syndrome,
hepatocellular carcinoma and autoimmune in all patients.
Anesthetic technique was standardized for all patients. All patients received preoperative
intravenous 40 mg of pantoprazole. Patients were monitored with three leads
electrocardiography, pulse oximeter, and noninvasive blood pressure. BIS recording
electrodes (Aspect Medical Systems. Inc., One Upland Road, Norwood, MA 02062 USA) were
applied to the forehead of each patient according to the manufacturer recommendations. The
BIS monitor was masked with opaque sheet and BIS data was recorded prior to induction of
general anesthesia then continued throughout the procedure. All information obtained from
the BIS monitor was continuously downloaded to a computer for offline analysis. The
patient's management was not guided by the changes in BIS readings. Before induction of
anesthesia, all patients were premedicated with 1-2 mg of intravenous midazolam.
Independent anesthetists, who were not involved in the collection and analysis of the
patient's data, provided the perioperative anesthetic management. After preoxygenation,
anesthesia was induced with lidocaine 0.75 mg/kg, propofol 1.5-2.0 mg/kg and fentanyl
2µg/kg. Rocuronium 1-1.2 mg/kg was given to suppress the first response on the train-of-four
(TOF) stimulations of the ulnar nerve. After tracheal intubation, the lungs were ventilated
with an inspired fraction of oxygen (FiO2) of 0.4 to maintain an arterial carbon dioxide
tension at 35-45 mm Hg and monitoring of end-tidal carbon dioxide and sevoflurane
concentration, direct arterial pressure monitoring through a radial artery catheter and a
tympanic membrane temperature were implemented.
A 7.5 Fr continuous thermodilution fiberoptic pulmonary artery catheter (CCO/SvO2) Edwards
Life Science, Irvine, CA, USA) was floated through the right internal jugular vein to the
right pulmonary artery using waveform and fluoroscopic guidance to measure cardiac output
using Angstrom AS5 Monitor (Datex - Ohmeda AS5, Microvitec Display LTD, Bolling Road,
Bradford, UK). The final position was confirmed by fluoroscopy and when PAOP less than
pulmonary artery diastolic pressure (PADP).
Anesthesia was maintained with 0.5-1.5 minimum alveolar concentration (MAC) of sevoflurane
and continuous intravenous infusion of fentanyl (1-3 µg/kg/h) titrated to maintain the mean
arterial blood pressure (MAP) and heart rate (HR) within 20% of their baseline values.
Rocuronium 0.1-0.3 mg/kg/h was used to maintain suppression of the second twitch in the TOF.
Normothermia was maintained using intravenous infusions of warm fluid and blood products and
water-filled thermal mattress according to the authors' protocol. Fluid boluses were given
in 250 ml aliquots of either 5% hydroxyethyl Starch 130/0.4 (Voluven® 6%, Fresenius Kabi,
Bad Hombourg, Germany) as needed to maintain the CVP and/or PAOP between 5 and 7 mm Hg and
the stroke volume (SV) within 20% of its baseline value. Albumin 5% was given as needed to
treat hypoalbuminemia. Transfusion of salvaged blood from the cell saver and packed red
blood cells was administered as clinically indicated to maintain a hemoglobin level ≥7 g/dL.
Intraoperative changes in electrolyte levels and acid-base balance were regularly monitored
and treated as appropriate. Hemodynamic control was standardized according to the authors'
center protocol. Hypotension (MAP decreased < 20% from the mean baseline and SVR < 600
dyne.sec-1.cm-5) was treated with boluses of fluids, ephedrine 5 mg, or epinephrine 5 µg, as
needed. Norepinephrine infusion was used for persistent hypotension with low SVR. Dobutamine
or epinephrine infusion was administered if the MAP was ≥ 70 mm Hg, CVP and/or PAOP ≥ 7 mm
Hg and the cardiac output was < 4.0 L. min-1. Hypertension (MAP increased > 20% from the
mean baseline) was treated with deepening of anesthesia, bolus doses of nitroglycerin 0.05
mg or labetalol 20 mg. Tachycardia (HR > 20% from the baseline values) was treated with
boluses of esmolol 20 mg.
All operations were performed by the same surgeons using the piggyback technique. After
portal vein clamping, infusion rates of fentanyl and rocuronium were reduced by
approximately 50%. Fentanyl and rocuronium infusions were discontinued after peritoneal
closure. After completion of skin closure, sevoflurane was discontinued. The patients were
transferred to the ICU immediately after surgery, while intubated and postoperative
analgesia was achieved with rescue boluses of fentanyl 0.5 µg/kg when needed.
Extubation criteria included cooperative, alertness, train-of-four ratio ≥ 0.9, spontaneous
breathing with tidal volume > 5 mL/kg, respiratory rate > 10 and < 28 breaths/min, maximum
inspiratory pressure ≤ -20 cm H2O, stable hemodynamics, minimal bleeding, core temperature >
35.5°C, urine output > 0.5 mL/Kg/h, arterial carbon dioxide tension ≤ 45 mm Hg, arterial
oxygen tension > 100 mm Hg and FiO2 < 50%.
On the second postoperative day, the patients were asked about perioperative awareness and
recall by asking three simple questions using standard interview "What was the last thing
you remembered happening before you went to sleep? What is the first thing you remember
happening on waking? Did you dream or have any other experiences whilst you were asleep?"
Another investigator, who was not involved in the patient's management, collected the saved
patients' data. Preoperative MELD score, durations of warm ischemia and anhepatic phase,
intraoperative blood loss and fentanyl consumption were collected. Preoperatively (baseline)
absolute values and intraoperative average values for BIS, Et-Sevo, heart rate (HR), MAP,
CVP, MPAP, CO, PAOP, SVR, PVR, core temperature, pH, PaCO2, PaO2, SaO2 SvO2, and PvO2 were
recorded during hepatic dissection, anhepatic, and neohepatic phases and during surgical
closure. Postoperative total bilirubin, albumin level, liver enzymes (AST, ALT, GGT, and
alkaline phosphatase), PT, factors V and VII, time to extubation, ICU and hospital length of
stays, neurological complication, encephalopathy and 3 months-mortality were recorded.
Data were tested for normality using the Kolmogorov-Smirnov test. Repeated-measures analysis
of variance was used for analysis of serial changes in the patients' data at different
times. Fisher exact test was used for categorical data. Postulated independent predictors of
BIS readings included age, gender, MELD score, durations of surgical phases and warm
ischemia, Et-Sevo, average of intraoperative hemodynamic, temperature, oxygenation and acid
base variables, intraoperative blood loss and fentanyl consumption, were examined in a
stepwise manner into a multiple regression model, with entry and retention set at a
significance level of P < 0.05 and removal set at P ≥ 0.1. Moreover, multivariate logistic
regression was done to identify the correlations between BIS values and blood loss, time to
tracheal extubation, postoperative liver function and coagulation variables, ICU length of
stay, and 3 months-mortality.
To evaluate the accuracy of BIS in predicting survival rate after liver transplantation,
receiver operating characteristic (ROC) curves were generated to describe the performance
characteristics of the BIS readings during different phases of surgery in predicting the
survival outcome. An ROC area of 1.0 is characteristic of an ideal model, whereas an area of
0.5 indicates a model of no diagnostic value. Cutoff values for mortality with the best
diagnostic sensitivity and specificity were derived from the ROC curve analyses. Unweighted
accuracy ((sensitivity + specificity) / 2) was also reported.
The studied patients were further divided according to their outcome variables into
survivors (n = 32) and non-survivors (n = 10) subgroups. Independent Student-t- and Mann
Whitney tests were used as appropriate. Data were expressed as mean (standard deviation),
number (%), or median [range]. A value of P < 0.05 was considered to represent statistical
significance.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04533932 -
Endosonographic Shear Wave Elastography for Liver Stiffness
|
||
| Not yet recruiting |
NCT06031740 -
A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids
|
N/A | |
| Not yet recruiting |
NCT06026267 -
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis
|
N/A | |
| Not yet recruiting |
NCT06076330 -
Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension
|
N/A | |
| Enrolling by invitation |
NCT05055713 -
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
|
N/A | |
| Recruiting |
NCT04578301 -
Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
|
||
| Not yet recruiting |
NCT05515861 -
Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices
|
N/A | |
| Not yet recruiting |
NCT05120557 -
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
|
N/A | |
| Not yet recruiting |
NCT03623360 -
Functional MRI to Determine Severity of Cirrhosis
|
||
| Not yet recruiting |
NCT02710227 -
Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis
|
N/A | |
| Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
| Active, not recruiting |
NCT02551250 -
Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
|
||
| Recruiting |
NCT02239991 -
Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant
|
N/A | |
| Enrolling by invitation |
NCT02256514 -
Open Label Trial of Immunotherapy for Advanced Liver Cancer
|
Phase 2 | |
| Terminated |
NCT02311985 -
Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial
|
N/A | |
| Terminated |
NCT01937130 -
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
|
Phase 2 | |
| Recruiting |
NCT01618890 -
Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding
|
Phase 3 | |
| Recruiting |
NCT01728688 -
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01728727 -
Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01724697 -
Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver Cirrhosis
|
Phase 1/Phase 2 |